RecruitingPhase 1NCT06859710

THC and CBD: A Controlled Human Study Probing a Harm Reduction Strategy

Interactions Between Delta-9-THC and CBD: A Controlled Human Drug-administration Study Probing a Harm Reduction Strategy

Sponsor

University of California, Los Angeles

Enrollment

30 participants

Start Date

Nov 5, 2025

Study Type

INTERVENTIONAL

Conditions

Pain Abuse, Drug

Summary

The purpose of this research is to assess the impact of CBD on the effects of THC.

Eligibility

Min Age: 21 YearsMax Age: 55 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called CBD 20 mg, a drug called CBD 40 mg, and others for people with abuse, drug and pain. The study is currently recruiting participants at 1 location. People eligible for this study include aged 21 Years to 55 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.